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Abstract The three-dimensional structure of chemically syn-
thesized CnErg1 (Ergtoxin), which speci¢cally blocks HERG
(human ether-a-go-go-related gene) K+ channels, was deter-
mined by nuclear magnetic resonance spectroscopy. CnErg1
consists of a triple-stranded L-sheet and an K-helix, as is typical
of K+ channel scorpion toxins. The peptide structure di¡ers
from the canonical structures in that the ¢rst L-strand is shorter
and is nearer to the second L-strand rather than to the third
L-strand on the C-terminus. There is also a large hydrophobic
patch on the surface of the toxin, surrounding a central lysine
residue, Lys13. We postulate that this hydrophobic patch is
likely to form part of the binding surface of the toxin.
, 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Recently, a new class of peptides from scorpion venom that
speci¢cally a¡ect Kþ channels of the ether-a-go-go-related
family of genes has been discovered and characterized [1^3].
This novel Q-Ktx family [4] includes potent peptides such as
CnErg1 (previously known as ErgTx [1]), BeKm-1 [5] and
CsEKerg1 [6], whose sequences range from 36 to 47 amino
acid residues. Structural studies on BeKm-1 toxin show that it
contains an K-helix and a triple-stranded L-sheet, typical of
Kþ channel scorpion toxins [7]. Interestingly, the most impor-
tant residues for toxin activity, Lys18 and Tyr11, are located
on the K-helix of BeKm-1, rather than the solvent-exposed
surface of the L-sheet which is more typical of scorpion Kþ
channel toxins [8,9]. Moreover, the separation of these two
residues is V12 AD , i.e. signi¢cantly greater than the
6.6E 1.0 AD typical of the functional dyad of scorpion toxins
that block Kþ channels [8]. There is, however, an additional
aromatic residue on the K-helix of BeKm-1, Phe14, that lies
approximately 6 AD from Lys18 and so Phe14/Lys18 may serve
as the functional dyad for BeKm-1 [7]. Nevertheless, the bind-
ing surface of BeKm-1 appears to be quite distinct from that
of other scorpion Kþ channel toxins.
The human ether-a-go-go-related gene (HERG) Kþ channel
is an important contributor to normal cardiac repolarization
[10]. Furthermore, loss-of-function mutations in the HERG
Kþ channel are the cause of long QT syndrome type-2, which
is associated with a markedly increased risk of ventricular
arrhythmias and sudden death [11]. One of the distinctive
features of the HERG Kþ channel is a long extracellular
loop linking the outer ends of the ¢fth transmembrane do-
main and the pore helix (S5-P loop) [12]. Mutations in this
loop a¡ect the rapid voltage dependent inactivation of the
HERG Kþ channel that is critical for its normal function [13].
CnErg1, like BeKm-1, binds to the S5-P loop of the HERG
Kþ channel [7,12]. Although CnErg1 and BeKm-1 are func-
tionally both members of the Q-Ktx family they share little
sequence homology and contain four and three disul¢de
bonds, respectively (Fig. 1A). Knowledge of the structure of
CnErg1 should therefore provide complementary structural
information and together with the BeKm-1 structure [7]
should help in mapping the HERG Kþ channel outer vesti-
bule, which is critically important for the unique function of
this channel.
We report here the three-dimensional fold of chemically syn-
thesized CnErg1 through the use of nuclear magnetic reso-
nance (NMR) spectroscopy. CnErg1 adopts an K-helix triple-
stranded L-sheet conformation typical of Kþ channel scorpion
toxins. Lys25 and Tyr17 in CnErg1 occur on the K-helix in a
similar orientation to that of Lys18 and Tyr11 in BeKm-1, i.e.
the residues most critical for activity of BeKm-1. However,
CnErg1 also contains a hydrophobic patch surrounding a
lysine residue, Lys13, located near the L-hairpin loop between
the second and third strands of the L-sheet which we postulate
may represent the binding site of CnErg1.
2. Materials and methods
2.1. Synthesis of CnErg1 and preparation of NMR sample
CnErg1 was synthesized manually on a 0.50 mmol scale using
HBTU (2-(1-H-benzotriazol-1-yl-)1,1,3,3 tetramethyluronium hexa-
£uorophosphate) activation of Boc-amino acids with in situ neutral-
ization chemistry as previously described [14]. Following HF cleavage,
the reduced peptides were isolated and puri¢ed using reverse-phase
high-performance liquid chromatography (RP-HPLC) using a C4 col-
umn. Disul¢de bond formation was carried out in 100 mM ammo-
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nium acetate (pH 7.5) and the ¢nal puri¢ed products were isolated by
preparative RP-HPLC as follows: fractions were collected, based on
monitoring the column e¥uent at 230 nm. Those fractions shown by
electrospray mass spectrometry analysis to contain solely the target
peptide were combined and lyophilized.
The NMR sample was prepared by dissolving 2.9 mg of the lyophi-
lized peptide in 0.350 ml of 90% H2O/10% D2O, resulting in a ¢nal
protein concentration of 1.7 mM and pH 3.2.
2.2. NMR spectroscopy
All NMR experiments were performed on a Bruker (Karlsruhe,
Germany) AVANCE-600 DRX spectrometer using a 5 mm 1H inverse
probe operating at temperatures of 20, 25, and 30‡C. Two-dimension-
al NMR spectra were acquired in phase-sensitive mode using time-
proportional phase detection [15]. The homonuclear two-dimensional
spectra recorded were total correlation spectroscopy (TOCSY) [16],
with spin-lock periods of 60 ms, and nuclear Overhauser enhancement
spectroscopy (NOESY) [17] with mixing times of 200 ms. Solvent-
signal suppression was achieved either by presaturation or by using
the WATERGATE [18] pulse sequence. H^D exchange experiments
were carried out by reconstituting the freeze-dried sample with D2O,
acquiring series of one-dimensional spectra for 30 min, and then ac-
quiring two 1 h TOCSY spectra. All spectra were processed using
XWIN-NMR software (Bruker) and were analyzed using the program
XEASY [19].
2.3. Structural calculations
The structure was obtained by using restraints consisting of 535
non-redundant NOE-derived distances, 32 hydrogen bonds, 11 P di-
hedral angles and 4 disul¢de bonds (see Table 1). The NOESY spec-
trum recorded at 25‡C with a mixing time of 200 ms provided the
NOE and dihedral angle constraints. The program INFIT [20] was
implemented to yield 3JNHK coupling constants from two-dimensional
NOESY spectra, which then provided P dihedral angle constraints
which were restrained as follows: 3120E 30‡ for 3JNHK =8^9 Hz
and 360E 40‡ for 3JNHK =5^6 Hz. Hydrogen-bonding pairs were de-
duced from H^D exchange experiments, and the preliminary calcu-
lated structures. Hydrogen-bonding constraints were only introduced
in the ¢nal stages of the structure calculations and were assigned
upper distance-limits of 2.2 AD for NHi to Oj and 3.2 AD for Ni to
Oj. The disul¢de bond con¢guration was determined from the char-
acteristic NOE interactions between the K and L protons of two-
paired cysteine residues. A summary of the NMR data for CnErg1
is presented in Fig. 2.
The NOAH protocol [21,22] in the torsion-angle dynamics program
DYANA [23] was used in calculating preliminary structures and in
assigning about 50% of non-intra-residue NOESY cross-peaks. The
standard simulated annealing procedure in DYANA was afterwards
implemented to improve the quality of structures by performing an
iterative cycle of calculations, structure analysis, manual assignment,
and constraint revision. Final DYANA calculation yielded 4000 struc-
tures, 80 of which (with the lowest NOE violations) were chosen for
re¢nement by using the standard simulated annealing script in CNS
[24]. In this re¢nement process, the high-temperature dynamics and
cooling cycle were performed in Cartesian space. The 20 structures
with the lowest overall energy were considered as representative of
CnErg1. Secondary structures in CnErg1 were determined using
MOLMOL [25].
The coordinates for the ensemble of 20 structures, including the
structural restraints, have been deposited in the RSCB Protein Data
Bank with accession code 1NE5. The chemical shift assignments were
deposited in the BioMagRes Bank with accession number 5652.
2.4. Electrophysiology
CHO cells stably transfected with HERG Kþ channels [26] were
voltage clamped in whole cell mode using an Axopatch 200B head-
stage ampli¢er (Axon instruments, CA, USA), as previously described
[27]. Currents were digitized on line using a digidata 1200 A/D con-
verter (Axon instruments, CA, USA) operated using pClamp8 soft-
ware. The internal solution contained (in mM): 120 K gluconate, 20
KCl, 1.5 MgATP, 5 EGTA, 10 HEPES (pH 7.3 with KOH). The bath
solution contained 130 NaCl, 4.8 KCl, 1.2 MgCl2, 1.2 NaH2PO4,
1 CaCl2, 10 glucose, 10 HEPES (titrated to pH 7.3 with NaOH) at
room temperature. CnErg1 was dissolved directly in bath solution at
doses ranging from 3 nM to 1 WM and applied using a picospritzer
(Intracell, Cambridge, UK).
3. Results and discussion
3.1. Veri¢cation of synthetic peptide
The amino acid sequence of the peptide synthesized in this
study is shown in Fig. 1A. Also shown are the disul¢de bond
pairings (5^23, 11^34, 20^39 and 24^41) as reported by Sca-
loni et al. [2]. With the absence of the native material for
comparison, the synthetic CnErg1 peptide was ¢rst tested
for activity to con¢rm that it was identical to that of the
native toxin. HERG Kþ channel activity was suppressed
V50% by 10 nM toxin (see Fig. 1B). The IC50 for inhibition
of HERG channels was 8.5 E 1.0 nM (n=3, see Fig. 1C) with
a maximum inhibition of 94E 1% both of which are very
similar to that reported in the literature [3,12]. We also found
that the observed NOEs in the NMR experiments were con-
sistent with the cysteine pairing pattern reported by Scaloni et
al. [2]. Thus, this synthetic peptide was concluded to be equiv-
alent to the native material.
3.2. Overall fold and secondary structures
The 1H NMR spectra obtained from the CnErg1 were of
high quality, making the analysis straightforward and yielding
a high-resolution structure. This is clearly exempli¢ed by the
ensemble of the 20 NMR structures shown in Fig. 3A. The
overall backbone root-mean-square deviation (rmsd) with re-
spect to the mean structure for residues 5^42 was 0.25 AD while
the corresponding heavy atom rmsd for these residues was
0.71 AD (Table 1).
The CnErg1 structure starts with a £exible N-terminal up to
residue 4 and is then followed by a turn-like structure, likely
to be a 310 helix, at residues 5^7. The ¢rst L-strand of the
triple-stranded antiparallel L-sheet is short, formed by resi-
dues 14^15. The remaining two antiparallel L-strands are de-
¢ned by residues 32^35 and 39^41; with an intervening L-hair-
pin loop at residues 35^37. An K-helix, formed by residues 18^
27, follows the ¢rst L-strand and traverses the three L-strands
diagonally (see Fig. 3B). The overall fold of CnErg1, with a
distinct K-helix and triple-stranded L-sheet, is similar to other
scorpion toxins that a¡ect Kþ and Naþ channels [4]. The
CnErg1 structure, however, is unusual among scorpion Kþ
channel toxins in that a turn or a short helix is situated at
the N-terminal end of the peptide instead of the more usual
¢rst strand of the L-sheet. Moreover, the ¢rst L-strand in
CnErg1 interacts (by hydrogen bond) with the second
Table 1
Structural statistics for the ensemble of 20 CnErg1 structures
Quantity Value
Distance restraints
Intraresidue (i3j=0) 207
Sequential (ji3jj=1) 134
Medium range (ji3jj9 5) 76
Long range (ji3jjs 5) 118
Hydrogen bonds 32
Total 567
Dihedral angle restraints
P 11
Atomic rmsd with the mean structure (A7 )
Backbone atoms (1^42) 0.57E 0.30
Heavy atoms (1^42) 1.15E 0.37
Backbone atoms (5^42) 0.25E 0.04
Heavy atoms (5^42) 0.71E 0.09
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L-strand and not the third L-strand, as found in many com-
mon scorpion toxins [9].
A DALI algorithm [28] search of similar structures in the
protein database revealed that the structural fold of CnErg1
has signi¢cant similarity to that of OSK1, a scorpion toxin
from Orhtochirus scrobiculosus that blocks Ca2þ-activated Kþ
channels [29]. Despite sequence identity of only 35%, about
80% of the residues in CnErg1 are found to be structurally
equivalent to that of OSK1. However, since important resi-
dues Lys27, Asn30, Gly31, His34, and Thr36 in OSK1 are
di¡erent from the corresponding residues in CnErg1, it can
be surmised that the binding sites for these two Kþ channel
molecules are di¡erent.
3.3. Structural implications
It has been proposed that that the ability of unrelated tox-
ins to recognized voltage-activated Kþ channels is due to the
presence of a dyad comprising of a lysine residue and an
aromatic residue separated by 6.6 E 1.0 AD [8]. Many of the
short scorpion Kþ channel toxins have these two important
residues residing on the solvent-exposed surface of the £at
L-sheet face [8]. BeKm-1, which shares a common structural
sca¡old with other short scorpion toxins, is di¡erent in that its
binding site for the HERG Kþ channel is situated on the helix
[7]. Furthermore, while the most critical lysine residue, Lys18,
in BeKm-1 is locatedV6 AD from an aromatic residue, Phe14,
the aromatic residue most critical for function of the toxin,
Tyr11, is located near the N-terminus of the helix and is
situated V12 AD from Lys18. The corresponding residues in
CnErg1, Lys25, Gln21 and Tyr17, are also located on the
helical part of the molecule. Clearly, Gln21 cannot ful¢l the
role of a functional dyad. Conversely, Lys38 which lies along
the L-sheet plane of the molecule, pointing towards the sol-
vent (see Fig. 3C), is separated from Phe36 on the L-hairpin
loop by V7 AD and easily satis¢es the criterion of the func-
tional dyad. Furthermore, Lys13 lies within 7 AD of Tyr14,
Phe36 and Phe37. Thus there are at least two potential func-
tional dyads present in CnErg1. Clari¢cation of the role of
these potential dyads and the K-helix as putative binding sites
(as is the case for BeKm-1) will require future mutagenesis
studies.
The binding of Kþ channel speci¢c scorpion toxins to their
receptors on the outer vestibule of the channel pore involves a
Fig. 1. Functional assessment of chemically synthesized CnErg1. A: Sequence alignment of CnErg1 (Ergtoxin) and BeKm-1 showing the pre-
dicted disul¢de bridges. The highlighted residues indicate those most important for BeKm-1 activity (Tyr11, Lys18, Arg20, Lys23) [7]. Tyr11
and Lys18 are conserved in CnErg1 (Tyr17 and Lys25). Alignment was performed using Clustal W [33]. The numbering above the sequences
corresponds to CnErg1. B: Representative current traces from a CHO cell transfected with HERG Kþ channels. During a depolarization step
from 380 to +20 mV channels open and then inactivate. During the subsequent repolarization step to 3120 mV the currents show the charac-
teristic ‘hook’ as channels rapidly recover from the inactive state into the open state before closing slowly. In this example, addition of 10 nM
CnErg1 caused 52% inhibition of the current. C: Dose response curve for CnErg1 blockade of HERG Kþ channels. The continuous curve
shows the best ¢t for the equation: % max current= 13A([toxin]/([toxin]+Kd)), where A is the maximum inhibition (94E1%, n=3) and Kd is
the a⁄nity of toxin for the HERG Kþ channel (8.5E 1.0 nM, n=3).
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Fig. 2. Summary of NMR data for Cnerg1. Slowly exchanging
backbone amides at 25‡C are indicated by circles, 3JNHK =8^9 Hz
by upward pointing arrows, and 3JNHK =5^6 Hz by downward
pointing arrows. Each NOE connectivity is represented by a shaded
horizontal bar whose thickness is proportional to the observed
NOE intensity; HK chemical shift indices (CSI) [34] are indicated
by vertical bars.
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combination of hydrophobic, hydrogen bonding, and electro-
static interactions [30^32]. The binding of Ergtoxin to HERG
channels, however, is not in£uenced by the extracellular [Kþ]
and does not involve strong electrostatic interactions [12]. It is
therefore likely that hydrophobic interactions will play a more
important role in Ergtoxin binding to HERG than is the case
for other scorpion toxins binding to their respective ion-chan-
nel receptors. A notable feature of the CnErg1 structure is the
presence of a large hydrophobic patch centered around an
aromatic cluster de¢ned by Tyr 14, Phe 36 and Phe 37 (see
Fig. 3D,E). Furthermore, in the middle of this hydrophobic
patch lies Lys13. It has been suggested that CnErg1 binds to
the hydrophobic surface of an amphipathic helix in the outer
vestibule of the HERG Kþ channel [12]. It has been shown
that mutations of hydrophobic residues on a putative amphi-
pathic helix in the extracellular linker between the ¢fth trans-
membrane domain and the pore helix (S5-P linker) signi¢-
cantly decrease the a⁄nity of CnErg1 for the HERG Kþ
channel [12]. Therefore, it is possible that hydrophobic inter-
actions may make a signi¢cant contribution to the interaction
of CnErg1 with the HERG Kþ channel.
Another interesting structural feature of CnErg1 is the pres-
ence of numerous acidic residues (Asp1, Asp3, Asp7, Asp22,
and Glu19) located on or near the helical side, opposite the
triple-stranded L-sheets. While few positively charged residues
are also present in this face of the molecule, it is nevertheless
possible that these negatively charged residues are important
in binding positively charged residues. Alternatively, they may
be involved in reorientating the CnErg1 as it docks to the
HERG Kþ channel outer vestibule. The outer vestibule of
the HERG Kþ channel contains numerous positively charged
residues including Arg582, Lys595, Lys608, Lys610 and
Lys638 [12]. Cysteine mutants of Arg582, Lys608 and
Lys610 did not a¡ect the a⁄nity of CnErg1. Cysteine mutants
of Lys595 and Lys638, however, were non-functional so it is
possible that these residues could be involved in toxin binding.
Con¢rmation of whether the charged residues in CnErg1 con-
tribute to docking of the toxin to the channel will be tested
using mutant cycle analysis experiments.
In conclusion, we have shown that the CnErg1 has a struc-
ture broadly similar to other scorpion toxins that inhibit Kþ
channels, containing a distinctive K-helix and triple-stranded
L-sheet. However, there are some important di¡erences most
notable of which is a large, solvent-exposed, hydrophobic
patch that could be important for docking CnErg1 to
HERG. This structure provides a useful starting point for
designing mutant cycle analysis experiments to help determine
the structure of the outer vestibule of the HERG Kþ channel.
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Fig. 3. The CnErg1 structure. A: Ensemble of the best 20 CnErg1 structures aligned by superimposing backbone atoms of residues 5^42.
B: Ribbon diagram showing secondary structures and disul¢de connectivities. C: Di¡erent view of the structure emphasizing the side-chains of
lysine residues. D: Ribbon diagram showing locations of important residues. Side-chain heavy atoms of Lys13 and Lys25 are shown in blue
while those of non-polar and Tyr residues are shown in yellow. E: Molecular surface showing hydrophilicity/hydrophobicity. The types of resi-
dues are distinguished by their color: non-polar and Tyr residues ^ yellow; polar uncharged residues ^ green; positively charged ^ blue; and
negatively charged ^ red. The ¢gures were generated using MOLMOL [25].
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